Global Conference on Engineered Cell Therapies and Immune-Based Medicines

Important dates

1. 11 Dec

   Abstract / full paper deadline

   In 26 days

2. 12 Jan

   Conference

   Lower Hutt, New Zealand

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

The scientific community is consistently advancing engineered cell therapies and immune-based medicines, making this conference pivotal for anyone dedicated to these fields. Attendees will benefit from diverse sessions covering research developments, ethical considerations, and innovative approaches to treatment. Researchers are invited to submit their studies in various formats for presentation, including novel preclinical findings and clinical insights. The program is designed to stimulate discussions around practical applications and regulatory issues affecting therapy implementation. Participants will have ample opportunities to connect with leading figures in the field, fostering collaboration and partnerships. A report summarizing the conference outcomes, as well as selected presentations for journal publication, will enrich the dialogue and ongoing research efforts. Engage with peers and shape the conversation surrounding engineered therapies and immune interventions.

Call for papers

Abstracts are due by 11 December 2026. Submission details are on the official website.